Washington Supreme Court Finds No Exception to Learned Intermediary Doctrine for Direct-to-Consumer Advertising
- June 03, 2022
Prescription drug manufacturers don’t have a duty to warn patients directly of a drug’s risk even where the company conducts direct-to-consumer advertising for the product, the Washington Supreme Court held June 2.
ARTICLE TAGS
You must be logged in to access this content.